Providing Access to the Visual Environment
Launched by VANDERBILT UNIVERSITY · Jun 20, 2006
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
The "Providing Access to the Visual Environment" trial aims to help children in Tennessee who have vision impairments. This program is designed for kids aged 3 to 21 who have difficulty seeing clearly, specifically those whose best-corrected vision is 20/50 or worse in their stronger eye. The goal is to provide them with special devices that can improve their vision and to train them on how to use these devices effectively.
To participate, children must be enrolled in a public or private school in Tennessee and have a visual impairment that qualifies them for services. However, children who cannot learn to read or use their vision for reading will not be eligible. If accepted into the program, participants can expect to receive personalized support and training to enhance their visual abilities, helping them to engage more fully in their daily activities and education.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children age 3 to 21 years of age Enrollment in a school in Tennessee (private or public)
- • - Children that are eligible for services due to visual impairment Low vision
- Exclusion Criteria:
- • Children who do not have the potential to become readers or use their vision for reading
About Vanderbilt University
Vanderbilt University is a prestigious research institution renowned for its commitment to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on collaboration across various disciplines, Vanderbilt leverages its state-of-the-art facilities and a diverse team of experts to conduct rigorous clinical studies. The university is dedicated to improving patient outcomes by exploring novel therapeutic interventions and enhancing understanding of disease mechanisms. Through its robust clinical research infrastructure, Vanderbilt University aims to contribute significantly to the scientific community and the development of effective healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Patients applied
Trial Officials
Lori Ann Kehler, O.D.
Principal Investigator
Vanderbilt Eye Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials